ribociclib
novartis
['natalee', ' ribo', 'ribociclib']
natalee: 3.3% absolute benefit in idfs with adjuvant ribociclib vs et #endcancer #asco23 #asco2023 
Associate Professor Breast Medical Oncology @MDAndersonNews. Associate Medical Director of the #BreastCancer Survivorship Clinic. All tweets are my own.